Glover A. Response: Letter to the editor: "Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program". Surgery 2025 Jan 3:109006. doi: 10.1016/j.surg.2024.109006.
PMID: 39755503